Key Points Interested in AtriCure, Inc.? Here are five stocks we like better. AtriCure posted strong Q2 2026 results, with ...

AtriCure (ATRC) reported $153.6 million in revenue for the quarter ended June 2026, representing a year-over-year increase of ...

AtriCure (NASDAQ:ATRC) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you ...

With a key FDA approval in hand for its cardiac ablation technology, device maker AtriCure (NASDAQ:ATRC) has its sights set on grabbing market share from industry giant Medtronic (NYSE:MDT). In ...

The "AtriCure Inc (ATRC) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable ...

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and ...

First and Only System in the United States Approved to Treat Patients with Persistent and Long-Standing Persistent Atrial Fibrillation WEST CHESTER, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ...

AtriCure offers medical devices for surgical ablation of cardiac tissue, including Isolator Synergy Clamps, MAX Pen, Coolrail, cryoICE Cryoablation System, EPi-Sense Guided Coagulation System, ...

October 27, 2011 (Rockville, Maryland) — The AtriCure Synergy Ablation System squeaked by today in a meeting of the Food and Drug Administration's Circulatory System Devices advisory panel when ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Atricure Inc. (NASDAQ: ATRC), the maker of cardiac surgical ablation systems, has received a conditional nod from the Food and Drug Administration (FDA) to evaluate the safety and efficacy of a hybrid ...

WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial ...